Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000498106 | SCV000590749 | uncertain significance | not provided | 2017-06-27 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the RYR2 gene. The c.14655+5 G>C variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is also not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Two of three in silico splice prediction programs predict this variant may reduce the efficiency of the natural donor site in intron 102 of the RYR2 gene, which may affect gene splicing. However, in the absence of functional mRNA studies, the physiological consequence of this variant cannot be precisely determined. Furthermore, no other splice site variants definitively associated with cardiomyopathy, or other RYR2-related disorders, have been reported in HGMD (Stenson et al., 2014). Lastly, this substitution occurs at a nucleotide that is not conserved across species. |